Abstract:Vast emerging evidences are linking the base modifications and determination of stem cell fate such as proliferation and differentiation. Among the base modification markers extensively studied, 5-methylcytosine (5-mC) and its oxidative derivatives (5-hydroxymethylcytosine (5-hmC), 5-formylcytosine (5-fC), and 5-carboxylcytosine (5-caC)) dynamically occur in DNA and RNA and have been acknowledged as important epigenetic markers involved in regulation of cellular biological processes. N6-Methyladenosine modification in DNA (m6dA), mRNA (m6A), tRNA, and other noncoding RNAs has been defined as another important epigenetic and epitranscriptomic marker in eukaryotes in recent years. The mRNA m6A modification has been characterized biochemically, molecularly, and phenotypically, including elucidation of its methyltransferase complexes (m6A writer), demethylases (m6A eraser), and direct interaction proteins (readers), while limited information on the DNA m6dA is available. The levels and the landscapes of m6A in the epitranscriptomes and epigenomes are precisely and dynamically regulated by the fine-tuned coordination of the writers and erasers in accordance with stages of the growth, development, and reproduction as naturally programmed during the lifespan. Additionally, progress has been made in appreciation of the link between aberrant m6A modification in stem cells and diseases, like cancers and neurodegenerative disorders. These achievements are inspiring scientists to further uncover the epigenetic mechanisms for stem cell development and to dissect pathogenesis of the multiple diseases conferred by development aberration of the stem cells. This review article will highlight the research advances in the role of m6A methylation modifications of DNA and RNA in the regulation of stem cell and genesis of the closely related disorders. Additionally, this article will also address the research directions in the future.

N6-Methyladenosine Methyltransferases and Demethylases: New Regulators of Stem Cell Pluripotency and Differentiation

Rna N-6-Methyladenosine Methylation In Post-Transcriptional Gene Expression Regulation

M6a-Binding Proteins: the Emerging Crucial Performers in Epigenetics

The emerging roles of N6-methyladenosine RNA methylation in human cancers

Regulation of RNA N6-methylation of adenosine on stem cell differentiation

N6-Methyladenosine in RNA and DNA: An Epitranscriptomic and Epigenetic Player Implicated in Determination of Stem Cell Fate

The Emerging Molecular Mechanism of M6a Modulators in Tumorigenesis and Cancer Progression

Role of DNA and RNA N-6-Adenine Methylation in Regulating Stem Cell Fate

The Roles of RNA N6-Methyladenosine in Regulating Stem Cell Fate

The N6-Methyladenosine RNA modification in pluripotency and reprogramming

M(6)a RNA Modification Controls Cell Fate Transition in Mammalian Embryonic Stem Cells.

RNA N6-Methyladenine Modification, Cellular Reprogramming, and Cancer Stemness

Regulation of N6-Methyladenosine in the Differentiation of Cancer Stem Cells and Their Fate

Steering pluripotency and differentiation with N6-methyladenosine RNA modification

The regulatory role of m 6 A modification in the maintenance and differentiation of embryonic stem cells

Epitranscriptomic M6a Modification in the Stem Cell Field and Its Effects on Cell Death and Survival.

N 6 -Methyladenosine Modification-Mediated Mrna Metabolism is Essential for Human Pancreatic Lineage Specification and Islet Organogenesis

N6-methyladenosine modifications: interactions with novel RNA-binding proteins and roles in signal transduction.

The Roles of M6a RNA Modifiers in Human Cancer

m(6)A RNA methylation is regulated by microRNAs and promotes reprogramming to pluripotency

N6‐methyladenosine RNA Methylation: A Novel Regulator of the Development and Function of Immune Cells